Lanchbury Jerry S's Form 4 filing
Myriad Genetics Inc (MYGN) · filed Jul 12, 2021
- Accession no.
- 0001219036-21-000016
- Filed
- Jul 12, 2021
- Trade date
- Jul 9, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.63M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lanchbury Jerry SCIK 0001219036 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2021 | Common Stock | MOption exerciseAcquired | +26,705 | $26.49 | +$707,415.45 | 259,255 | Direct | |
| Jul 9, 2021 | Common Stock | SSaleDisposed | −26,705 | $32.79 | −$875,656.95 | 232,550 | Direct | |
| Jul 9, 2021 | Common Stock | MOption exerciseAcquired | +5,603 | $26.49 | +$148,423.47 | 238,153 | Direct | |
| Jul 9, 2021 | Common Stock | SSaleDisposed | −5,603 | $32.29 | −$180,920.87 | 232,550 | Direct | |
| Jul 9, 2021 | Common Stock | MOption exerciseAcquired | +17,692 | $19.47 | +$344,463.24 | 250,242 | Direct | |
| Jul 9, 2021 | Common Stock | SSaleDisposed | −17,692 | $32.47 | −$574,459.24 | 232,550 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2021 | Common Stock | MOption exerciseDisposed | −17,692 | $0.00 | $0 | 0 | Direct | |
| Jul 9, 2021 | Common Stock | MOption exerciseDisposed | −26,705 | $0.00 | $0 | 115,123 | Direct | |
| Jul 9, 2021 | Common Stock | MOption exerciseDisposed | −5,603 | $0.00 | $0 | 109,520 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.